Skip to content
10-Q

Quarterly Report

Cell Source, Inc. CLCS

0001493152-26-022926

← back to feed
Filed
May 14, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 13, 2026 67.95M sh
Shares Diluted Q1 2025 · Mar 31, 2025 45.04M sh
Shares Diluted Q1 2025 · Mar 31, 2024 40.51M sh
Operating Cash Flow Q1 2025 · Mar 31, 2025 −$600.39K
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$173.85K
Stockholders Equity Q1 2025 · Mar 31, 2025 −$20.14M
Stockholders Equity Q1 2025 · Dec 31, 2024 −$18.54M
Stockholders Equity Q1 2025 · Mar 31, 2024 −$16.75M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$15.61M
Total Liabilities Q1 2025 · Mar 31, 2025 $20.43M
Total Liabilities Q1 2025 · Dec 31, 2024 $18.82M
Total Assets Q1 2025 · Mar 31, 2025 $292.45K
Total Assets Q1 2025 · Dec 31, 2024 $286.5K
Eps Diluted Q1 2025 · Mar 31, 2025 −$0.04
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.04
Eps Basic Q1 2025 · Mar 31, 2025 −$0.04
Eps Basic Q1 2025 · Mar 31, 2024 −$0.04
Net Income Q1 2025 · Mar 31, 2025 −$1.48M
Net Income Q1 2025 · Mar 31, 2024 −$1.28M
Operating Income Q1 2025 · Mar 31, 2025 −$998.59K
Operating Income Q1 2025 · Mar 31, 2024 −$1.14M